Light Detection and Ranging (LiDAR): Technologies and Global Markets


#1377228

132pages

BCC Research

$ $4950

In Stock


The global clinical next-generation sequencing (NGS) market reached $2.7 billion in 2016. This market is expected to grow at a compound annual growth rate (CAGR) of 27%, from nearly $3.2 billion in 2017 to $10.5 billion by 2022.
Non-cancer applications as a segment should reach $2.3 billion in 2017 to $6.4 billion by 2020, at a CAGR of 22.3% from 2017 to 2022.
Cancer applications as a segment should reach $838.8 million in 2017 to nearly $4.1 billion by 2022, at a CAGR of 37.3% from 2017 to 2022.

##img_1##